Peachey NS, Pearring JN, Bojang P Jr, Hirschtritt ME, Sturgill-Short G, Ray TA, Furukawa T, Koike C, Goldberg AF, Shen Y, McCall MA, Nawy S, Nishina PM, Gregg RG. Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation. J Neurophysiol 108: 2442 -2451 . First published August 15, 2012 doi:10.1152 /jn.00137.2012 are found in humans with an autosomal recessive form of complete congenital stationary night blindness (cCSNB). The Trpm1 Ϫ/Ϫ mouse has been an important animal model for this condition. Here we report a new mouse mutant, tvrm27, identified in a chemical mutagenesis screen. Genetic mapping of the no b-wave electroretinogram (ERG) phenotype of tvrm27 localized the mutation to a chromosomal region that included Trpm1. Complementation testing with Trpm1 Ϫ/Ϫ mice confirmed a mutation in Trpm1. Sequencing identified a nucleotide change in exon 23, converting a highly conserved alanine within the pore domain to threonine (p.A1068T). Consistent with prior studies of Trpm1 Ϫ/Ϫ mice, no anatomical changes were noted in the Trpm1 tvrm27/tvrm27 retina. The Trpm1 tvrm27/tvrm27 phenotype is distinguished from that of Trpm1 Ϫ/Ϫ by the retention of TRPM1 expression on the dendritic tips of depolarizing bipolar cells (DBCs). While ERG b-wave amplitudes of Trpm1 ϩ/Ϫ heterozygotes are comparable to wild type, those of Trpm1 ϩ/tvrm27 mice are reduced by 32%. A similar reduction in the response of Trpm1 ϩ/tvrm27 DBCs to LY341495 or capsaicin is evident in whole cell recordings. These data indicate that the p.A1068T mutant TRPM1 acts as a dominant negative with respect to TRPM1 channel function. Furthermore, these data indicate that the number of functional TRPM1 channels at the DBC dendritic tips is a key factor in defining DBC response amplitude. The Trpm1 tvrm27/tvrm27 mutant will be useful for elucidating the role of TRPM1 in DBC signal transduction, for determining how Trpm1 mutations impact central visual processing, and for evaluating experimental therapies for cCSNB. TRP channel; electroretinogram; congenital stationary night blindness; depolarizing bipolar cell LIGHT-INDUCED HYPERPOLARIZATION of photoreceptors results in a decline in presynaptic glutamate release onto the dendrites of bipolar and horizontal cells. Hyperpolarization is conserved in horizontal and hyperpolarizing bipolar cells as a result of postsynaptic ionotropic glutamate receptors. In contrast, photoreceptor hyperpolarization is inverted in depolarizing bipolar cells (DBCs) as a result of a decrease in activation of postsynaptic metabotropic glutamate receptor 6 (GRM6) and subsequent opening of a transient receptor potential melastatin 1 protein (TRPM1)-containing cation-selective channel (Koike et al. 2010a (Koike et al. , 2010b Morgans et al. 2009 Morgans et al. , 2010 Shen et al. 2009; Shiells et al. 1981; Slaughter and Miller 1981) .
Mutations in several genes disrupt photoreceptor-to-DBC synaptic transmission. Most encode proteins that control glutamate release from photoreceptor terminals or play a role in DBC signal transduction. Several are implicated in the Schubert-Bornschein (1952) class of congenital stationary night blindness (CSNB). Miyake et al. (1986) divided Schubert-Bornschein CSNB into "incomplete" (iCSNB) and "complete" (cCSNB) forms on the basis of clinical examination and functional characteristics. In this classification, the electroretinogram (ERG) is a critical test: while both iCSNB and cCSNB have normal a-waves, indicating preserved photoreceptor function (Penn and Hagins 1969) , they differ with respect to the extent of involvement of postreceptoral ERG components (b-waves and oscillatory potentials). In patients with iCSNB, b-waves and oscillatory potentials are present but significantly reduced in amplitude, while in patients with cCSNB these response components are absent.
Mutations in CACNA1F and in CABP4 have been implicated in iCSNB (Bech-Hansen 1998; Strom et al. 1998; Zeitz et al. 2006) , and both mediate photoreceptor glutamate release. In comparison, all four genes associated with human cCSNB (NYX: Bech-Hansen 2000; Pusch et al. 2000; GRM6: Dryja et al. 2005; Zeitz et al. 2005 ; TRPM1: Audo et al. 2009; Li et al. 2009; Nakamura et al. 2010; van Genderen et al. 2009; GPR179: Audo et al. 2012; Peachey et al. 2012 ) are expressed by DBCs, and ERG analyses show a comparable no b-wave (nob) phenotype observed in mouse mutants for Nyx (Gregg et al. 2007; Pardue et al. 1998) , Grm6 (Maddox et al. 2008; Masu et al. 1995; Pinto et al. 2007 ), Gpr179 (Peachey et al. 2012) , and Trpm1 (Koike et al. 2010a; Morgans et al. 2009; Shen et al. 2009 ). The availability of these models provides important opportunities to understand cCSNB and to evaluate experimental treatments for this disorder.
In this study, we report a new mouse model identified through an ERG screen of chemically mutagenized mice in the Translational Vision Research Models (TVRM) program of The Jackson Laboratory (Won et al. 2011) . The nob phenotype we document in homozygous tvrm27 mutant mice is caused by a point mutation in the Trpm1 gene that affects the pore domain of the protein. The Trpm1 tvrm27/tvrm27 mutant will be a valuable model for human cCSNB due to TRPM1 point mutations and will be useful in furthering our understanding of how TRPM1 channels function, how TRPM1 interacts with other proteins required for normal DBC signal transduction, and the role of TRPM1 with respect to trafficking and localization of the various components of the DBC signal transduction cascade.
METHODS
Mice and mapping. All procedures used in animal experiments were approved by the Institutional Animal Care and Use Committees of the institutions involved. Homozygous tvrm27 mice were identified from a mutagenesis program (Won et al. 2011) . Male C57BL/6J mice were mutagenized with ethylnitrosourea that was administered in intraperitoneal injections of 80 mg/kg for 3 wk (Justice et al. 2000) . G3 offspring, generated by using a three-generation backcross mating scheme to identify recessive mutations (Herron et al. 2002) , were screened by an ERG protocol (Hawes et al. 2000) to identify mice with abnormal ERGs.
Trpm1 tm1Lex/tm1Lex , hereafter referred to as Trpm1 Ϫ/Ϫ mice, were generated by Lexicon Genetics and acquired from the European Mouse Mutant Archive (www.emmanet.org). DBA/2J mice were obtained from The Jackson Laboratory. Grm6 nob3 (Maddox et al. 2008 ) mice were obtained from The Jackson Laboratory. Nyx nob (Pardue et al. 1998) and Gpr179 nob5 (Peachey et al. 2012 ) mutant mice were obtained from our local breeding colonies.
DNA was prepared from tail biopsies by proteinase K digestion and isopropyl alcohol extraction. DNA samples isolated from 261 tvrm27 F2 progeny were genotyped with 103 simple sequence length polymorphic markers distributed throughout the genome (Taylor et al. 1994) .
Sequencing. Total RNA was isolated from retinas with TRIzol reagent per the manufacturer's protocol (Life Technologies, Carlsbad, CA). cDNA was synthesized from total RNA with SuperScript II reverse transcriptase per the manufacturer's protocol (GE Biosystems).The entire coding region of Trpm1 was amplified with primers [Trpm1-001 (5=-ATGGGGTCCATGAGGAA-3=) and Trpm1-003 (5=-TCAGCACTCAGTTTCCGCGC-3=)], cloned, and sequenced on an Applied Biosystems (Carlsbad, CA) 3130XL Sequencer (using a 50-cm array and POP7 polymer). The causative mutation was confirmed to be present in genomic DNA.
Electroretinography. After overnight dark adaptation, mice were anesthetized with ketamine (80 mg/kg) and xylazine (16 mg/kg) and their pupils were dilated with 1% tropicamide and 2.5% phenylephrine HCl eye drops. ERGs were recorded with a stainless steel wire contacting the anesthetized (1% proparacaine HCl) corneal surface that was referenced to a needle electrode placed in the cheek; a second needle electrode placed in the tail served as ground. Responses were amplified (0.03-1,000 Hz) and stored with an LKC (Gaithersburg, MD) UTAS E-3000 signal averaging system. For screening, a single flash luminance was used (1.4 log cd s/m 2 ). ERGs were also recorded under stimulus conditions that allow the response properties of rodand cone-driven components to be defined with published protocols (Chang et al. 2006; Gregg et al. 2007) .
Electron and confocal microscopy: immunohistochemistry. Eyes enucleated from mice killed by anesthetic overdose were placed in fresh fixative (2.5% glutaraldehyde-2% paraformaldehyde, 100 mM cacodylate, pH 7.4) for 30 min. Tissues were postfixed with 1% OsO 4 for 1 h, en bloc stained with 2% uranyl acetate for 30 min, dehydrated in a graded ethanol series, and infiltrated and embedded in medium (Polybed 812; Polysciences, Warrington, PA). Thin sections were cut with an ultramicrotome (MT 7000; Ventana, Tucson, AZ), collected onto nickel grids, stained with 2% uranyl acetate and lead citrate, and imaged in a transmission electron microscope (Morgagni; FEI, Hillsboro, OR) at 80 kV. Additional details regarding these procedures are provided by Goldberg et al. (2007) . Retinal structure and ribbon synapse ultrastructure were examined in both eyes of two wild-type (WT) and two Trpm1 tvrm27/tvrm27 mice.
For confocal microscopy, dissected retinas were immersion fixed for 15 min in 4% (wt/vol) paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB), then washed in PB, cryoprotected through a graded sucrose series, and frozen in OCT (Sakura Finetek, Torrence, CA)-20% sucrose (2:1; Barthel and Raymond 1990) . Sixteen-micrometer sections were cut on a cryostat, mounted onto SuperFrost glass slides, air-dried, and stored at Ϫ80°C.
Sections were brought to room temperature, washed in PBS for 5 min and in PBS containing 0.5% (vol/vol) Triton X-100 (PBX) for 5 min and then incubated in blocking solution [PBX containing 5% (vol/vol) normal goat serum] for 1 h. Primary antibodies were diluted in blocking solution and incubated on retinal sections at room temperature overnight. Primary antibodies and dilutions used were anti-GRM6 (1:1,000; Koike et al. 2010a ), anti-TRPM1 (1:100; Koike et al. 2010a) , and anti-RIBEYE (1:1,000; BD Biosciences). After incubation with the primary antibody, sections were washed three times in PBS for 5 min each and subsequently incubated with fluorescently labeled secondary antibodies (1:1,000 in blocking solution) at room temperature for 1 h. Secondary antibodies were Alexa 488 goat anti-rabbit and Alexa 555 goat anti-mouse (Invitrogen, Carlsbad, CA). Slides were then washed three times in PBS and coverslipped with Immunomount (Thermo Shandon, Pittsburgh, PA). Sections were imaged on an Olympus (Center Valley, PA) FV1000 confocal microscope with a ϫ60 oil objective (1.45 NA). Images shown are maximum projections of confocal stacks, adjusted for contrast and brightness with FluoView software.
Bipolar cell patch-clamp electrophysiology. After death, whole retinas were isolated from 4-to 6-wk-old mice and placed on a 0.65-m cellulose acetate-nitrate membrane filter (Millipore, Billerica, MA) secured with vacuum grease to a glass slide adjacent to the recording chamber. Retinal slices (100 m) were cut with a tissue slicer (Stoelting, Wood Dale, IL), transferred to the recording chamber while remaining submerged, and viewed with a Nikon (Tokyo, Japan) E600FN upright microscope equipped with a water-immersion ϫ40 objective and DIC optics. Slices were continuously perfused with Ames medium bubbled with 95% O 2 -5% CO 2 . In all experiments, inhibitory conductances were blocked with 100 M picrotoxin (Sigma-Aldrich, St. Louis, MO), 10 M strychnine (Sigma-Aldrich), and 50 M (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (Sigma-Aldrich). Patch pipettes of resistance 7-9 M⍀ were fabricated from borosilicate glass (WPI, Sarasota, Fl) with a two-stage vertical puller (Narishige, Tokyo, Japan) and filled with a K ϩ gluconate-based solution that also contained (in mM) 0.5 EGTA, 10 HEPES, 4 ATP, and 1 GTP (pH 7.4 by CsOH) and 14 g/ml Alexa 488 (Invitrogen). The mGluR6 agonist L-AP4 (4 M; Tocris Bioscience, Ellisville, MO) was added to the bath, and pharmacological agents [metabotropic receptor antagonist LY341495 (Tocris Bioscience), TRP channel agonist capsaicin (Sigma-Aldrich)] were delivered to the retina from a pipette with positive pressure (2-4 psi) with a computercontrolled solenoid valve (Picospritzer; General Valve, Fairfield, NJ). Retinal dissection, manipulations, and recordings were made in room light.
RESULTS
The nob ERG phenotype in homozygous tvrm27 mice is caused by a missense mutation in Trpm1. To map the tvrm27 locus, affected mice were crossed to WT DBA/2J mice and the resulting F1 mice were intercrossed. F2 progeny homozygous for the tvrm27 locus were identified by ERG and their DNA genotyped with microsatellite markers across the genome. The tvrm27 phenotype was mapped to chromosome 7, between markers D7MIT230 and D7MIT195. This region contained Trpm1, which we considered an excellent candidate gene because Trpm1 Ϫ/Ϫ mice are reported to have a similar ERG phenotype (Koike et al. 2010a; Morgans et al. 2009; Shen et al. 2009 ). To test whether tvrm27 was a new allele of Trpm1, we crossed homozygous tvrm27 mice to Trpm1 Ϫ/Ϫ mice. All F1 offspring from this complementation cross lacked the ERG b-wave, indicating that tvrm27 is an allele of Trpm1, hence-forth referred to as Trpm1 tvrm27 . The responsible mutation was identified by sequencing cDNA clones representing the Trpm1 tvrm27 allele. A single nucleotide change c.G3399A (accession no. AY180104) resulted in an alanine to threonine missense mutation at position 1068 (p.A1068T; Fig. 1A ). A1068 lies in the TRPM1 channel pore region ( Fig. 1B) and is invariant in all mammals sequenced to date as well as in other vertebrates including platypus, zebra finch, and pufferfish (Fig. 1C) .
Retinal anatomy is normal in Trpm1 tvrm27/tvrm27 mice. We examined retinal anatomy by light and electron microscopy (Fig. 2) . Examination of retinal cross sections of control and Trpm1 tvrm27/tvrm27 mice showed normal cellular and synaptic layers ( Fig. 2A) . Furthermore, ultrastructural analyses indicated that Trpm1 tvrm27/tvrm27 rod (Fig. 2B) and cone (Fig. 2C) photoreceptor terminals have normal ribbon synapses (Fig.  2B) . Thus the abnormal ERG phenotype of Trpm1 tvrm27/tvrm27 mice cannot be attributed to a loss of DBCs or a gross disruption of synaptic structure.
Trpm1 expression is preserved in Trpm1 tvrm27/tvrm27 retina. Because Trpm1 tvrm27/tvrm27 results from a missense mutation, we examined whether the mutant protein was expressed and localized similarly to WT. We double-labeled WT, Trpm1 tvrm27/tvrm27 , and Trpm1 Ϫ/Ϫ retina sections with antibodies to TRPM1 and GRM6 (Fig. 3) . Consistent with published data (Koike et al. 2010a; Pearring et al. 2011) , WT retina had TRPM1 puncta on the tips of DBC dendrites and also diffuse label throughout their cell body (Fig. 3A ). GRM6 label (Fig.  3B ) colocalized with the TRPM1-positive puncta (Fig. 3C) . The expression patterns of both TRPM1 and GRM6 were similar in the Trpm1 tvrm27/tvrm27 retina (Fig. 3, D-F) . In contrast, the Trpm1 Ϫ/Ϫ retina lacked TRPM1 staining and maintained the WT distribution for GRM6 ( Fig. 3, G-I) . These data show that the mutant TRPM1 p.A1068T protein is correctly localized, indicating that the nob ERG phenotype in the Trpm1 tvrm27/tvrm27 mutant is caused by a loss of channel function.
To further characterize GRM6 expression in the Trpm1 tvrm27/tvrm27 retina, we incubated sections with antibodies to GRM6 and RIBEYE, a component of the photoreceptor ribbon complex. As can be seen in Fig. 4 , TRPM1 expression on WT (Fig. 4A) and Trpm1 tvrm27/tvrm27 (Fig. 4B ) dendritic tips is surrounded by RIBEYE expression. Taken together, the data in Figs. 3 and 4 show that the expression of GRM6 and TRPM1 is comparable in WT and Trpm1 tvrm27/tvrm27 DBCs.
Trpm1 tvrm27 mice lack an ERG b-wave. To further characterize the Trpm1 tvrm27 mutant, we recorded ERGs under darkand light-adapted conditions (Fig. 5 ). Dark-adapted ERGs obtained from representative WT and Trpm1 tvrm27/tvrm27 mice are shown in Fig. 5A . Throughout the luminance range examined, WT ERGs are dominated by the positive-polarity b-wave, which increases in amplitude with increasing luminance and reflects light-induced activity of DBCs (Kofuji et al. 2000) . At higher luminances, the b-wave is preceded by the negativepolarity a-wave, reflecting the light-induced closure of cation channels along rod photoreceptor outer segments (Penn and Hagins 1969) . In comparison, the b-wave component is absent from responses of Trpm1 tvrm27/tvrm27 mice. The net result is that the a-wave is followed by slow PIII, a negative-polarity component generated by Kir4.1 channel activity in Müller glial cells (Kofuji et al. 2000; Samuels et al. 2010 ) that is normally masked by the larger-amplitude b-wave. This nob ERG phenotype, in which the b-wave is absent while the a-wave is preserved, indicates that rod phototransduction is unaffected by the mutation, while DBC activity is grossly abnormal (cf. McCall and Gregg 2008) . Figure 5B compares light-adapted ERGs obtained from representative WT and Trpm1 tvrm27/tvrm27 mice. Under these conditions the ERG represents activity of the cone pathway. The WT cone ERG is dominated by the positive-polarity b-wave and high-frequency oscillatory potentials, which reflect activity through the DBC pathway (Sharma et al. 2005; Shirato et al. 2008) . In contrast, the Trpm1 tvrm27/tvrm27 cone ERGs are electronegative and rarely rise above the prestimulus baseline. This abnormal cone ERG waveform closely matches that of Trpm1 Ϫ/Ϫ (Koike et al. 2010a; Morgans et al. 2009 ) as well as other DBC mutants (Nyx: Pardue et al. 1998; Grm6: Maddox et al. 2008; Pinto et al. 2007 ; Gpr179: Peachey et al. 2012) .
DBC function is reduced in Trpm1 ϩ/tvrm27 heterozygotes. Mutant TRPM1 tvrm27 protein is correctly localized in Trpm1 tvrm27/tvrm27 retina (Fig. 3) ; therefore the molecular com- position of TRPM1 channels in Trpm1 ϩ/tvrm27 heterozygotes should be heterogeneous. Since TRP channels are tetramers (Clapham 2003; Moiseenkova-Bell et al. 2008; Stewart et al. 2010) , individual channels can incorporate 0 -4 Trpm1 tvrm27 subunits. If WT and mutant (M) proteins are expressed at equal levels and participate equally in channel formation, the expected distribution of channels across the five possible stoichiometries is: 6.25% WT(4)M(0); 25% WT(3):M(1); 37.5% WT(2):M(2); 25% WT(1):M(3) and 6.25% WT(0)M(4). To investigate whether p.A1068T mutant subunits can coassemble with WT to generate a dominant-negative effect, we compared DBC function of WT mice to Trpm1 ϩ/tvrm27 and Trpm1 ϩ/Ϫ heterozygotes, using dark-adapted ERGs and patch-clamp recordings in retinal slices.
Representative WT, Trpm1 ϩ/tvrm27 , and Trpm1 ϩ/Ϫ darkadapted ERGs and summary data from multiple animals are shown in Fig. 6 . These results show that the a-waves in all three genotypes are indistinguishable. Furthermore, the bwaves of WT and Trpm1 ϩ/Ϫ mice are also comparable. In contrast, Trpm1 ϩ/tvrm27 b-waves are reduced across an ϳ5-log unit range of flash luminance (Fig. 6, A and B) . Across flash luminance, the average Trpm1 ϩ/tvrm27 b-wave amplitude was 32% less than the WT response. These results indicate that the p.A1068T mutant subunit integrates into TRPM1 tetramers. The extent of the b-wave reduction is consistent with a simple model in which channels containing 0 -2 mutant subunits (68.75% of all possible combinations) retain function while those containing either 3 or 4 mutant subunits (31.25%) are dysfunctional.
To determine whether heterozygous mouse models for other cCSNB genes (Nyx, Grm6, Gpr179) exhibit a similar selective ERG b-wave reduction, we also recorded dark-adapted ERGs from Grm6 ϩ/nob3 Gpr179 ϩ/nob5 compound heterozygous mice and Nyx ϩ/nob female mice and compared their results to WT littermates. To minimize variability across groups of mice due to factors such as age and genetic background, responses of each mouse were normalized to the maximum a-wave amplitude. Figure 6C presents luminance-response functions for Grm6 ϩ/nob3 Gpr179 ϩ/nob5 and Nyx ϩ/nob mice and their combined WT littermates. The b-wave response functions of Grm6 ϩ/nob3 Gpr179 ϩ/nob5 double heterozygotes and WT mice superimpose. In comparison, Nyx ϩ/nob heterozygote b-waves are consistently reduced in amplitude, consistent with X inactivation and DBCs expressing either Nyx ϩ or Nyx nob .
We used whole cell patch-clamp electrophysiology to directly examine the function of TRPM1 channels in rod DBCs. Application of either the mGluR6 antagonist LY341495 or the TRP agonist capsaicin (Caterina et al. 1997; Shen et al. 2009 ) evokes robust responses from WT DBCs (Fig. 7) . Under the same conditions, the current-voltage relationships for LY341495 and capsaicin are similar, and both responses are blocked by capsazepine (Shen et al. 2009 ). The waveforms of the Trpm1 ϩ/tvrm27 DBC responses were similar to WT but were reduced in amplitude (Fig. 7) . The variability in response waveform is reflective of our experience across multiple studies (Rampino et al. 2011; Shen et al. 2009 Shen et al. , 2012 and may reflect variability in diffusion characteristics of individual puffs as well as the location of the puffer pipette with respect to the membrane patch being analyzed. In comparison, responses of Trpm1 tvrm27/tvrm27 DBCs under these conditions were indistinguishable from background noise (Fig. 7) . Figure   Fig 7B summarizes response amplitudes to LY34195 and capsaicin application from WT, Trpm1 ϩ/tvrm27 , and Trpm1 tvrm27/tvrm27 DBCs. These results show that the presence of the p.A1068T protein in Trpm1 ϩ/tvrm27 DBCs decreases their response amplitude by 49% for LY341495 and 42% for capsaicin, compared with WT. This decrease is comparable to the decrease (32%) seen in the amplitude of the ERG b-wave.
DISCUSSION
TRPM1 was identified as a potential cause of night blindness in Appaloosa horses (Bellone et al. 2008 ) some 30 years after Witzel et al. (1978) documented that they were night blind and had a nob ERG phenotype. Subsequently, several independent groups reported that Trpm1 Ϫ/Ϫ mice have a nob ERG phenotype (Koike et al. 2010a; Morgans et al. 2009; Shen et al. 2009 ) and lack a DBC response to light (Koike et al. 2010a ). In human studies, TRPM1 mutations have been identified in a subset of patients with cCSNB (Audo et al. 2009; Li et al. 2009; Nakamura et al. 2010; van Genderen et al. 2009 ) and a nob ERG phenotype was reported in a patient with a homozygous microdeletion of 15q13.3 that includes TRPM1 (Lepichon et al. 2010; Spielmann et al. 2011) . Serum antibodies against TRPM1 have been identified in patients with melanoma-associated retinopathy, an acquired form of DBC dysfunction (Dhingra et al. 2011; Kondo et al. 2011) . In CHO cells transfected with TRPM1, GRM6, and GNA0, TRPM1 channel activity is modulated by GRM6 activation via GNA0 (Koike et al. 2010a ). Together, these results provide strong evidence that TRPM1 is the DBC transduction channel.
In this report, we describe a new mutant allele of Trpm1 that was generated as part of a large-scale mutagenesis program (Won et al. 2011) . The Trpm1 tvrm27 allele results from a missense mutation, p.A1068T, in TRPM1. Ala1068 is located in the predicted pore region of the channel (Xu et al. 2001 ) and is highly conserved in vertebrates, including marsupials, other mammals, birds, fish and amphibians. This level of conservation and the absence of any other detectable mutation suggest that Ala1068 is critical for channel function and that p.A1068T is the mutation responsible for the abnormalities observed in Trpm1 tmrm27/tvrm27 mice.
Trpm1 tvrm27/tvrm27 retinal anatomy at the light and electron microscopic level is normal. This is similar to descriptions of retinal anatomy in other mouse DBC signal transduction mutants (Grm6, Maddox et al. 2008; Masu et al. 1995; Pinto et al. 2007 ; Nyx, Ball et al. 2003; Pardue et al. 1998 Pardue et al. , 2001 Gpr179, Peachey et al. 2012) , although some components of DBC ribbon synapses are mislocalized in Grm6 Ϫ/Ϫ mice (Ishii et al. 2009 ). This is in contrast to mouse models for iCSNB genes and related proteins in which the outer plexiform layer collapses, ribbon synapses are malformed, and second-order neurons elaborate ectopic neurites (Cacna1f, Bayley and Morgans 2007; Chang et al. 2006; Mansergh et al. 2005; Cacnb2, Ball et al. 2002; Cacna2d4, Ruether et al. 2000; Wycisk et al. 2006; Cabp4, Haeseleer et al. 2004) .
TRPM1 channel density sets the maximum response amplitude of DBCs. To date, all studies of cCSNB mouse models have involved mutants with null alleles. Our data indicate that Trpm1 tvrm27 is not a null allele but is instead a nonfunctional allele that is correctly localized to the DBC tips. We have used this mutation to begin to identify the rate-limiting steps in DBC signal transduction. Mice heterozygous for the Trpm1 tvrm27 allele show decreased ERG b-wave and DBC response amplitudes to light or the activation of TRPM1 by capsaicin or of GRM6 by LY34195, respectively. In contrast, heterozygotes for the TRPM1 knockout allele have a normal ERG. DBC function is also normal in mice heterozygous for null alleles of Grm6 (Fig. 5C ), Gpr179 (Peachey et al. 2012) or Gna0 (Okawa et al. 2010) . These results indicate that none of these proteins is rate-limiting, even when expressed at half the WT level. This is not unexpected given their roles in the early Fig. 7 . Patch-clamp responses of rod depolarizing bipolar cells (DBCs). A: representative responses of WT, Trpm1 ϩ/tvrm27 , and Trpm1 tvrm27/tvrm27 littermates to the mGluR6 agonist LY341495 or the TRP channel antagonist capsaicin. B: average peak response amplitude for WT (n ϭ 7), Trpm1 ϩ/tvrm27 (n ϭ 4), and Trpm1 tvrm27/tvrm27 (n ϭ 5) rod DBCs with a holding potential of ϩ40 mV. Error bars indicate SE. **P ϭ 0.002; *P ϭ 0.01. stages of DBC signal transduction. In contrast, the incorporation of mutant TRPM1 tvrm27 subunits disrupts a substantial fraction of TRPM1 channels, leading to reduced DBC function.
We propose that b-wave amplitude is dependent on the number of functional TRPM1 channels at the tips of the DBCs. This predicts reduced b-wave amplitudes in other mutants that impair normal TRPM1 expression, such as the Nyx ϩ/nob mouse, because TRPM1 expression at the tips of DBCs depends on Nyx expression (Pearring et al. 2011) . In Nyx ϩ/nob female heterozygotes, because of X inactivation, approximately half of the DBCs express the WT allele and the other half express the Nyx nob mutant allele. Consistent with our proposal, the Nyx ϩ/nob ERG b-wave amplitude is decreased. These data also predict that ERG b-wave reductions will be observed in female carriers of NYX mutations. Finally, b-wave reductions would also be expected in individuals heterozygous for TRPM1 mutations that are nonfunctional but trafficked normally. It will be important for future studies to fully characterize these individuals to determine whether they have previously unappreciated visual abnormalities.
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